Misty L Mahaffey, NP

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Misty L Mahaffey’s office at (650) 723-4000 to ask if they take your plan before you enroll.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$44,417

Medicare paid this office $44,417 for 185 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Long return visit (40+ min)	53	$20,171	$143
Long return visit (40+ min)	66	$14,500	$104
Biopsy and aspiration of bone marrow sample for diagnosis	62	$3,489	$55
Return visit (30+ min)	19	$1,731	$64
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	16	$817	$23

See all 7 services

Sort by

Every Original Medicare service billed

Long return visit (40+ min)	53	$20,171	$143
Long return visit (40+ min)	66	$14,500	$104
Biopsy and aspiration of bone marrow sample for diagnosis	62	$3,489	$55
Return visit (30+ min)	19	$1,731	$64
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	16	$817	$23
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	12	$607	$25
Short return visit	12	$296	$25

Procedures Medicare counted

Sort by

Procedure volume Medicare published

Skin biopsy	1-10	None

Procedures year by year

Procedures billed to Original Medicare by year
Procedure	2019	2020	2021	2022	2023	2024
Biopsy and aspiration of bone marrow sample for diagnosis	29	58	53	110	34	63

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

185 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 12% · Women 51% · Also on Medicaid 18% · Health risk score 2.65. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 73% · Coronary heart disease 34% · Chronic kidney disease 33% · Diabetes 30% · Heart failure 30% · Atrial fibrillation 25% · Cancer 19% · Depression 19% · COPD 16% · Dementia 14% · Stroke 10%.

The office billed $264,975, Medicare allowed $58,215 and paid $44,417; for 491 services of 16 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	185	491	75	2.65	$264,975	$44,417
2023	120	239	76	2.43	$123,928	$20,438
2022	183	251	73	2.73	$102,709	$15,161
2021	118	160	75	2.40	$54,102	$8,739
2020	135	196	74	2.98	$80,096	$9,503
2019	88	119	70	2.88	$72,498	$5,842
2018	113	154	72	2.81	$110,571	$7,906
2017	147	275	71	2.91	$254,050	$11,237
2016	54	102	70	2.21	$114,748	$3,326

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 4 services

Sort by

Original Medicare services billed in 2023

Long return visit (40+ min)	61	$15,113	$112
Biopsy and aspiration of bone marrow sample for diagnosis	34	$1,905	$56
Return visit (30+ min)	12	$1,554	$78
Office for the evaluation and management of established patient that may not require presence of healthcare professional	14	$90	$6

2022: 6 services

Sort by

Original Medicare services billed in 2022

Biopsy and aspiration of bone marrow sample for diagnosis	100	$6,266	$57
Return visit (30+ min)	39	$3,425	$78
Long return visit (40+ min)	16	$2,219	$117
Short return visit (20+ min)	18	$1,109	$53
Administration of chemotherapy into fluid-filled space between the tissue that cover the brain and spinal cord	11	$957	$60
Office for the evaluation and management of established patient that may not require presence of healthcare professional	18	$112	$6

2021: 5 services

Sort by

Original Medicare services billed in 2021

Biopsy and aspiration of bone marrow sample for diagnosis	51	$3,092	$58
Short return visit (20+ min)	30	$1,505	$46
Return visit (30+ min)	15	$1,383	$81
Administration of chemotherapy into fluid-filled space between the tissue that cover the brain and spinal cord	11	$1,228	$58
Office for the evaluation and management of established patient that may not require presence of healthcare professional	13	$93	$7

2020: 6 services

Sort by

Original Medicare services billed in 2020

Biopsy and aspiration of bone marrow sample for diagnosis	54	$3,414	$59
Long return visit (40+ min)	19	$1,640	$68
Return visit (30+ min)	31	$1,568	$48
Short return visit (20+ min)	17	$735	$37
Short return visit	14	$304	$19
Office for the evaluation and management of established patient that may not require presence of healthcare professional	15	$103	$6

2019: 5 services

Sort by

Original Medicare services billed in 2019

Biopsy and aspiration of bone marrow sample for diagnosis	29	$1,799	$62
Return visit (30+ min)	26	$1,769	$59
Long return visit (40+ min)	11	$879	$80
Short return visit (20+ min)	18	$596	$33
Office for the evaluation and management of established patient that may not require presence of healthcare professional	12	$79	$6

2018: 5 services

Sort by

Original Medicare services billed in 2018

Biopsy and aspiration of bone marrow sample for diagnosis	48	$2,993	$61
Long return visit (40+ min)	19	$1,696	$81
Return visit (30+ min)	21	$1,259	$55
Short return visit (20+ min)	27	$1,136	$37
Office for the evaluation and management of established patient that may not require presence of healthcare professional	13	$84	$6

2017: 7 services

Sort by

Original Medicare services billed in 2017

Biopsy of bone marrow	63	$3,798	$57
Return visit (30+ min)	34	$2,458	$60
Long return visit (40+ min)	18	$1,863	$85
Short return visit (20+ min)	29	$1,371	$37
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service	48	$349	$7
Short return visit	16	$309	$18
Office for the evaluation and management of established patient that may not require presence of healthcare professional	21	$145	$7

2016: 2 services

Sort by

Original Medicare services billed in 2016

Biopsy of bone marrow	41	$2,428	$56
Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service	37	$266	$7

Drugs they prescribed that Part D paid

$18,545,930

Pharmacies billed $18,545,930 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 2% of their Part D prescriptions (54 of 2,378) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.

0 generic and 1,325 brand-name prescriptions · $18,545,930 in drug cost · 63 antibiotic prescriptions to 33 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Jakafi	174	$2,904,181	$16,691
Calquence	139	$2,149,373	$15,463
Revlimid	109	$1,947,727	$17,869
Pomalyst	87	$1,803,023	$20,724
Brukinsa	109	$1,445,892	$13,265

See all 46 drugs

Sort by

Every Part D drug this clinician prescribed

Jakafi	174	$2,904,181	$16,691
Calquence	139	$2,149,373	$15,463
Revlimid	109	$1,947,727	$17,869
Pomalyst	87	$1,803,023	$20,724
Brukinsa	109	$1,445,892	$13,265
Imbruvica	67	$1,135,314	$16,945
Lenalidomide	67	$955,822	$14,266
Promacta	61	$797,780	$13,078
Venclexta	80	$740,916	$9,261
Idhifa	23	$737,297	$32,056
Sprycel	55	$569,731	$10,359
Jaypirca	21	$470,989	$22,428
Ayvakit	11	$430,242	$39,113
Ninlaro	21	$273,815	$13,039
Bosulif	19	$231,279	$12,173
Eliquis	140	$120,647	$862
Inqovi	13	$107,079	$8,237
Procrit	11	$57,835	$5,258
Doptelet	14	$55,162	$3,940
Xarelto	39	$51,210	$1,313
Imatinib Mesylate	40	$43,540	$1,088
Posaconazole	13	$23,503	$1,808
Deferasirox	23	$23,158	$1,007
Hydroxyurea	149	$3,928	$26
Acyclovir	163	$3,069	$19
Cyclosporine Modified	12	$2,340	$195
Mercaptopurine	13	$2,107	$162
Entecavir	24	$1,608	$67
Dexamethasone	52	$928	$18
Valacyclovir	23	$810	$35
Oxycodone	21	$442	$21
Allopurinol	35	$384	$11
Prochlorperazine Maleate	26	$253	$10
Potassium Chloride	14	$239	$17
Levofloxacin	13	$238	$18
Duloxetine	16	$235	$15
Omeprazole	17	$191	$11
Famotidine	13	$187	$14
Hydrocodone-Acetaminophen	12	$179	$15
Sulfamethoxazole-Trimethoprim	22	$172	$8
Ondansetron	29	$166	$6
Prednisone	29	$149	$5
Lorazepam	16	$75	$5
Montelukast	11	$54	$5
Chlorhexidine Gluconate	14	$12	$1
Paxlovid	15	$0	$0

Year by year

Sort by

Part D prescribing by year

2024	2,378	466	2% (54)	56%	$18,545,930
2023	1,766	402	3% (55)	55%	$12,963,536
2022	1,986	351	4% (83)	52%	$13,805,843
2021	1,268	283	4% (51)	44%	$6,469,802
2020	1,058	256	3% (31)	None	$5,097,126
2019	884	233	4% (31)	51%	$4,077,302
2018	858	217	7% (63)	45%	$3,884,972
2017	871	205	7% (60)	44%	$3,555,686
2016	312	94	10% (30)	24%	$624,321

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 34 drugs

Sort by

Part D drugs prescribed in 2023

Revlimid	None	131	$2,375,825	$18,136
Jakafi	None	111	$1,958,382	$17,643
Pomalyst	None	70	$1,525,704	$21,796
Imbruvica	None	69	$1,093,531	$15,848
Calquence	None	42	$726,518	$17,298
Lenalidomide	None	43	$626,278	$14,565
Brukinsa	None	45	$587,629	$13,058
Promacta	None	45	$538,939	$11,976
Ayvakit	None	12	$441,684	$36,807
Idhifa	None	12	$383,197	$31,933
Venclexta	None	53	$374,138	$7,059
Besremi	None	20	$307,758	$15,388
Bosulif	None	21	$251,463	$11,974
Ninlaro	None	18	$241,319	$13,407
Sprycel	None	25	$230,509	$9,220
Imatinib Mesylate	None	48	$106,526	$2,219
Eliquis	None	96	$90,751	$945
Panzyga	Immune globulin	13	$79,126	$6,087
Pegasys	None	23	$70,601	$3,070
Xarelto	None	45	$50,601	$1,124
Zarxio	None	21	$31,905	$1,519
Acyclovir	None	157	$4,616	$29
Hydroxyurea	None	97	$3,545	$37
Entecavir	None	14	$1,315	$94
Oxycodone	None	22	$798	$36
Dexamethasone	None	52	$732	$14
Allopurinol	None	37	$530	$14
Potassium Chloride	None	12	$517	$43
Prochlorperazine Maleate	None	30	$307	$10
Montelukast	None	15	$249	$17
Ondansetron	None	20	$224	$11
Prednisone	None	18	$168	$9
Ondansetron Odt	None	14	$168	$12
Chlorhexidine Gluconate	None	16	$68	$4

2022: 39 drugs

Sort by

Part D drugs prescribed in 2022

Revlimid	178	$3,273,283	$18,389
Pomalyst	111	$2,218,240	$19,984
Jakafi	109	$1,932,130	$17,726
Imbruvica	111	$1,678,296	$15,120
Venclexta	68	$593,988	$8,735
Promacta	47	$498,281	$10,602
Sprycel	36	$419,025	$11,640
Calquence	22	$335,955	$15,271
Besremi	18	$273,467	$15,193
Lenalidomide	12	$185,661	$15,472
Imatinib Mesylate	71	$171,602	$2,417
Procrit	25	$111,748	$4,470
Eliquis	92	$74,684	$812
Pegasys	18	$66,015	$3,667
Xarelto	37	$33,718	$911
Posaconazole	14	$32,433	$2,317
Oxycontin	11	$14,777	$1,343
Acyclovir	187	$4,198	$22
Entecavir	19	$3,984	$210
Enoxaparin	15	$3,796	$253
Hydroxyurea	88	$2,861	$33
Oxycodone	31	$1,459	$47
Dexamethasone	62	$1,061	$17
Ondansetron	40	$1,041	$26
Valacyclovir	19	$907	$48
Morphine Sulfate Er	15	$753	$50
Levofloxacin	34	$570	$17
Allopurinol	39	$552	$14
Gabapentin	22	$500	$23
Penicillin V	13	$451	$35
Potassium Chloride	11	$337	$31
Prednisone	29	$305	$11
Montelukast	24	$252	$11
Hydrocodone-Acetaminophen	14	$126	$9
Lorazepam	12	$117	$10
Amlodipine Besylate	11	$117	$11
Prochlorperazine Maleate	13	$114	$9
Zolpidem	13	$94	$7
Sulfamethoxazole-Trimethoprim	11	$75	$7

2021: 27 drugs

Sort by

Part D drugs prescribed in 2021

Imbruvica	106	$1,499,120	$14,143
Revlimid	72	$1,304,506	$18,118
Jakafi	53	$889,215	$16,778
Pomalyst	31	$532,458	$17,176
Promacta	21	$375,798	$17,895
Venclexta	43	$371,446	$8,638
Sprycel	13	$205,535	$15,810
Imatinib Mesylate	52	$81,525	$1,568
Procrit	17	$71,902	$4,230
Deferasirox	11	$61,421	$5,584
Eliquis	59	$44,074	$747
Xarelto	35	$26,435	$755
Acyclovir	180	$3,904	$22
Hydroxyurea	64	$2,853	$45
Dexamethasone	58	$1,615	$28
Ondansetron	48	$1,468	$31
Valacyclovir	15	$673	$45
Levofloxacin	18	$560	$31
Oxycodone	15	$453	$30
Morphine Sulfate Er	12	$448	$37
Pantoprazole	11	$287	$26
Allopurinol	16	$284	$18
Gabapentin	16	$278	$17
Potassium Chloride	11	$239	$22
Ondansetron Odt	15	$209	$14
Prednisone	15	$128	$9
Montelukast	15	$81	$5

2020: 19 drugs

Sort by

Part D drugs prescribed in 2020

Imbruvica	107	$1,377,127	$12,870
Revlimid	60	$1,036,847	$17,281
Jakafi	54	$750,807	$13,904
Promacta	47	$606,860	$12,912
Venclexta	54	$437,464	$8,101
Pomalyst	15	$282,602	$18,840
Sprycel	18	$266,546	$14,808
Eliquis	47	$26,344	$561
Xarelto	40	$25,907	$648
Acyclovir	152	$2,883	$19
Hydroxyurea	45	$2,631	$58
Ondansetron	25	$576	$23
Dexamethasone	24	$496	$21
Potassium Chloride	13	$438	$34
Allopurinol	26	$334	$13
Ondansetron Odt	12	$324	$27
Prochlorperazine Maleate	19	$257	$14
Prednisone	29	$173	$6
Sulfamethoxazole-Trimethoprim	15	$40	$3

2019: 16 drugs

Sort by

Part D drugs prescribed in 2019

Jakafi	80	$1,114,175	$13,927
Imbruvica	82	$928,150	$11,319
Sprycel	31	$437,323	$14,107
Venclexta	36	$291,544	$8,098
Revlimid	14	$214,829	$15,345
Tasigna	18	$188,652	$10,481
Imatinib Mesylate	12	$74,407	$6,201
Xarelto	44	$27,060	$615
Eliquis	33	$19,496	$591
Acyclovir	117	$1,818	$16
Hydroxyurea	42	$1,313	$31
Morphine Sulfate Er	11	$407	$37
Dexamethasone	18	$388	$22
Prednisone	34	$255	$7
Allopurinol	17	$188	$11
Gabapentin	11	$151	$14

2018: 22 drugs

Sort by

Part D drugs prescribed in 2018

Jakafi	77	$1,010,223	$13,120
Imbruvica	76	$879,229	$11,569
Sprycel	31	$398,877	$12,867
Rydapt	13	$395,752	$30,442
Imatinib Mesylate	35	$241,815	$6,909
Gleevec	12	$127,798	$10,650
Promacta	18	$116,755	$6,486
Xarelto	23	$18,557	$807
Eliquis	17	$13,608	$800
Welchol	11	$7,315	$665
Hydroxyurea	48	$3,159	$66
Cyclosporine Modified	12	$3,079	$257
Acyclovir	78	$1,211	$16
Morphine Sulfate Er	17	$665	$39
Oxycodone	13	$616	$47
Potassium Chloride	16	$605	$38
Valacyclovir	17	$575	$34
Ranitidine	12	$432	$36
Ondansetron Odt	16	$294	$18
Dexamethasone	13	$253	$19
Allopurinol	13	$216	$17
Zolpidem	11	$96	$9

2017: 21 drugs

Sort by

Part D drugs prescribed in 2017

Jakafi	103	$1,179,573	$11,452
Imbruvica	86	$915,035	$10,640
Sprycel	27	$266,046	$9,854
Ninlaro	22	$207,600	$9,436
Imatinib Mesylate	27	$198,922	$7,367
Promacta	18	$101,531	$5,641
Eliquis	26	$11,989	$461
Xarelto	15	$7,369	$491
Hydroxyurea	51	$2,576	$51
Ondansetron Odt	11	$1,016	$92
Morphine Sulfate Er	13	$745	$57
Oxycodone	13	$738	$57
Potassium Chloride	22	$621	$28
Acyclovir	43	$606	$14
Hydrocodone-Acetaminophen	12	$415	$35
Azathioprine	12	$349	$29
Dexamethasone	27	$270	$10
Allopurinol	12	$186	$16
Prednisone	12	$152	$13
Sulfamethoxazole-Trimethoprim	16	$81	$5
Pantoprazole	15	$53	$4

2016: 6 drugs

Sort by

Part D drugs prescribed in 2016

Jakafi	22	$275,786	$12,536
Imbruvica	14	$145,084	$10,363
Hydroxyurea	14	$573	$41
Acyclovir	22	$309	$14
Allopurinol	21	$294	$14
Dexamethasone	12	$115	$10

Money from drug and device companies

$2,041 in 2025

Sort by

Industry payments by year

2025	17	48	None	$2,041
2024	16	39	None	$1,059
2023	11	16	None	$701
2022	5	10	None	$298
2021	3	3	None	$147

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

E.R. Squibb & Sons L.L.C.	Opdivo	$381	3 payments Meals for Breyanzi · 2025-09-30 · $132 Meals for Opdivo · 2025-09-09 · $122 Meals for Opdivo · 2025-02-11 · $128
Janssen Biotech	Rybrevant	$306	6 payments Meals for Talvey · 2025-11-10 · $39 Meals for Talvey · 2025-10-06 · $26 Meals for Talvey · 2025-08-18 · $34 Meals for Darzalex · 2025-06-24 · $70 Meals for Rybrevant · 2025-05-12 · $132 Meals for Rybrevant · 2025-05-05 · $5
Syndax Pharmaceuticals	Revuforj	$292	2 payments Meals for Revuforj · 2025-11-03 · $145 Meals for Revuforj · 2025-05-13 · $147
Rigel Pharmaceuticals	Tavalisse	$256	6 payments Meals for Rezlidhia · 2025-11-17 · $121 Meals for Tavalisse · 2025-09-22 · $30 Meals for Tavalisse · 2025-09-22 · $19 Meals for Tavalisse · 2025-04-02 · $32 Meals for Tavalisse · 2025-02-25 · $28 Meals for Tavalisse · 2025-01-22 · $25
Daiichi Sankyo	Vanflyta	$216	8 payments Meals for Vanflyta · 2025-09-29 · $30 Meals for Vanflyta · 2025-07-31 · $29 Meals for Vanflyta · 2025-06-27 · $21 Meals for Injectafer · 2025-06-10 · $28 Meals for Injectafer · 2025-05-20 · $25 Meals for Vanflyta · 2025-04-17 · $26 Meals for Vanflyta · 2025-02-28 · $29 Meals for Vanflyta · 2025-01-23 · $28
AstraZeneca Pharmaceuticals LP	Calquence	$155	7 payments Meals for Calquence · 2025-12-24 · $17 Meals for Calquence · 2025-12-22 · $26 Meals for Calquence · 2025-10-28 · $30 Meals for Calquence · 2025-10-07 · $25 Meals for Calquence · 2025-08-13 · $23 Meals for Calquence · 2025-04-15 · $22 Meals for Calquence · 2025-03-27 · $13

See all 48 published payments

Sort by

Every published payment

AstraZeneca Pharmaceuticals LP	Meals · 2025-12-24	Calquence	$17
AstraZeneca Pharmaceuticals LP	Meals · 2025-12-22	Calquence	$26
GlaxoSmithKline	Meals · 2025-12-02	Blenrep	$17
Stemline Therapeutics	Meals · 2025-11-29	Elzonris	$29
Rigel Pharmaceuticals	Meals · 2025-11-17	Rezlidhia	$121
Janssen Biotech	Meals · 2025-11-10	Talvey	$39
Syndax Pharmaceuticals	Meals · 2025-11-03	Revuforj	$145
AstraZeneca Pharmaceuticals LP	Meals · 2025-10-28	Calquence	$30
PharmaEssentia USA	Meals · 2025-10-27	Besremi	$19
AstraZeneca Pharmaceuticals LP	Meals · 2025-10-07	Calquence	$25
Janssen Biotech	Meals · 2025-10-06	Talvey	$26
E.R. Squibb & Sons L.L.C.	Meals · 2025-09-30	Breyanzi	$132
Daiichi Sankyo	Meals · 2025-09-29	Vanflyta	$30
BeOne Medicines USA	Meals · 2025-09-29	Brukinsa	$29
Rigel Pharmaceuticals	Meals · 2025-09-22	Tavalisse	$30
Rigel Pharmaceuticals	Meals · 2025-09-22	Tavalisse	$19
E.R. Squibb & Sons L.L.C.	Meals · 2025-09-09	Opdivo	$122
BeOne Medicines USA	Meals · 2025-09-08	Brukinsa	$33
Servier Pharmaceuticals	Meals · 2025-09-08	Tibsovo	$23
Regeneron Healthcare Solutions	Meals · 2025-09-05	Lynozyfic	$25
Celgene	Meals · 2025-08-19	Reblozyl	$19
Janssen Biotech	Meals · 2025-08-18	Talvey	$34
AstraZeneca Pharmaceuticals LP	Meals · 2025-08-13	Calquence	$23
Daiichi Sankyo	Meals · 2025-07-31	Vanflyta	$29
Regeneron Healthcare Solutions	Meals · 2025-07-21	Lynozyfic	$24
Abbvie	Meals · 2025-07-15	Imbruvica	$24
Daiichi Sankyo	Meals · 2025-06-27	Vanflyta	$21
Janssen Biotech	Meals · 2025-06-24	Darzalex	$70
PharmaEssentia USA	Meals · 2025-06-24	Besremi	$19
Daiichi Sankyo	Meals · 2025-06-10	Injectafer	$28
Geron	Meals · 2025-06-09	Rytelo	$66
Daiichi Sankyo	Meals · 2025-05-20	Injectafer	$25
Syndax Pharmaceuticals	Meals · 2025-05-13	Revuforj	$147
Janssen Biotech	Meals · 2025-05-12	Rybrevant	$132
Janssen Biotech	Meals · 2025-05-05	Rybrevant	$5
BeOne Medicines USA	Meals · 2025-04-22	Brukinsa	$21
Daiichi Sankyo	Meals · 2025-04-17	Vanflyta	$26
AstraZeneca Pharmaceuticals LP	Meals · 2025-04-15	Calquence	$22
Rigel Pharmaceuticals	Meals · 2025-04-02	Tavalisse	$32
AstraZeneca Pharmaceuticals LP	Meals · 2025-03-27	Calquence	$13
Abbvie	Meals · 2025-03-25	Epkinly	$30
Daiichi Sankyo	Meals · 2025-02-28	Vanflyta	$29
Rigel Pharmaceuticals	Meals · 2025-02-25	Tavalisse	$28
E.R. Squibb & Sons L.L.C.	Meals · 2025-02-11	Opdivo	$128
Merck Sharp & Dohme	Meals · 2025-01-31	Welireg	$28
Incyte	Meals · 2025-01-28	Jakafi	$27
Daiichi Sankyo	Meals · 2025-01-23	Vanflyta	$28
Rigel Pharmaceuticals	Meals · 2025-01-22	Tavalisse	$25

See earlier years (2024, 2023, 2022, 2021)

2024: $1,059

Sort by

Payments by company in 2024

Abbvie	Venclexta	$379	11 payments Meals for Venclexta · 2024-11-19 · $125 Meals for Imbruvica · 2024-09-20 · $26 Meals for Venclexta · 2024-08-22 · $3 Meals for Venclexta · 2024-08-22 · $19 Meals for Imbruvica · 2024-08-21 · $20 Meals for Imbruvica · 2024-08-21 · $4 Meals for Epkinly · 2024-08-20 · $34 Meals for Venclexta · 2024-05-01 · $17 Meals for Venclexta · 2024-05-01 · $12 Meals for Venclexta · 2024-03-26 · $88 Meals for Epkinly · 2024-03-19 · $31
AstraZeneca Pharmaceuticals LP	Calquence	$109	4 payments Meals for Calquence · 2024-11-25 · $28 Meals for Calquence · 2024-11-05 · $28 Meals for Calquence · 2024-09-24 · $31 Meals for Calquence · 2024-04-16 · $22
Merck Sharp & Dohme	Keytruda	$83	3 payments Meals for Keytruda · 2024-10-25 · $31 Meals for Keytruda · 2024-09-10 · $29 Meals for Keytruda · 2024-07-12 · $23
Rigel Pharmaceuticals	Rezlidhia	$78	4 payments Meals for Rezlidhia · 2024-06-26 · $21 Meals for Rezlidhia · 2024-03-05 · $29 Meals for Rezlidhia · 2024-01-23 · $2 Meals for Rezlidhia · 2024-01-23 · $26
Janssen Biotech	Darzalex	$60	2 payments Meals for Darzalex · 2024-12-16 · $23 Meals for Darzalex · 2024-08-27 · $36
Kite Pharma	Yescarta	$46	2 payments Meals for Yescarta · 2024-08-26 · $24 Meals for Yescarta · 2024-05-31 · $22
PharmaEssentia USA	Besremi	$43	2 payments Meals for Besremi · 2024-12-17 · $21 Meals for Besremi · 2024-08-23 · $22
Incyte	Jakafi	$42	2 payments Meals for Jakafi · 2024-10-08 · $24 Meals for Jakafi · 2024-05-25 · $18
Daiichi Sankyo	Vanflyta	$38	2 payments Meals for Vanflyta · 2024-12-11 · $21 Meals for Vanflyta · 2024-10-01 · $17
Legend Biotech USA	None	$35	1 payment Meals · 2024-05-07 · $35
Lilly USA	Verzenio	$30	1 payment Meals for Verzenio · 2024-09-18 · $30
Celgene	Pomalyst	$29	1 payment Meals for Pomalyst · 2024-04-17 · $29
Servier Pharmaceuticals	Oncaspar	$24	1 payment Meals for Oncaspar · 2024-05-28 · $24
Adaptive Biotechnologies	Clonoseq	$23	1 payment Meals for Clonoseq · 2024-12-03 · $23
Pfizer	Bosulif	$23	1 payment Meals for Bosulif · 2024-08-29 · $23
E.R. Squibb & Sons L.L.C.	Opdivo	$18	1 payment Meals for Opdivo · 2024-10-29 · $18

2023: $701

Sort by

Payments by company in 2023

Janssen Biotech	Tecvayli	$223	5 payments Meals for Darzalex · 2023-05-31 · $27 Meals for Imbruvica · 2023-04-18 · $30 Meals for Imbruvica · 2023-04-17 · $8 Meals for Tecvayli · 2023-03-20 · $125 Meals for Carvykti · 2023-03-06 · $33
E.R. Squibb & Sons L.L.C.	Onureg	$115	1 payment Meals for Onureg · 2023-03-29 · $115
Incyte	Jakafi	$112	2 payments Education · 2023-09-29 · $91 Meals for Jakafi · 2023-05-10 · $21
AstraZeneca Pharmaceuticals LP	Calquence	$55	1 payment Meals for Calquence · 2023-05-23 · $55
Pharmacyclics LLC An AbbVie	Imbruvica	$41	1 payment Meals for Imbruvica · 2023-03-08 · $41
Janssen Scientific Affairs	Imbruvica	$32	1 payment Meals for Imbruvica · 2023-07-26 · $32
CTI BioPharma	Vonjo	$28	1 payment Meals for Vonjo · 2023-04-25 · $28
Takeda Pharmaceuticals U.S.A.	Iclusig	$27	1 payment Meals for Iclusig · 2023-10-10 · $27
BeiGene USA	Brukinsa	$24	1 payment Meals for Brukinsa · 2023-02-14 · $24
Abbvie	Venclexta	$24	1 payment Meals for Venclexta · 2023-09-29 · $24
GlaxoSmithKline	Ojjaara	$20	1 payment Meals for Ojjaara · 2023-11-13 · $20

2022: $298

Sort by

Payments by company in 2022

Amgen	Kyprolis	$156	3 payments Meals for Nplate · 2022-10-24 · $25 Meals for Kyprolis · 2022-10-18 · $105 Meals for Kyprolis · 2022-09-12 · $27
Janssen Biotech	Carvykti	$63	3 payments Meals for Carvykti · 2022-10-26 · $24 Meals for Imbruvica · 2022-10-18 · $19 Meals for Carvykti · 2022-07-19 · $20
Pharmacyclics LLC an AbbVie	Imbruvica	$44	2 payments Meals for Imbruvica · 2022-09-27 · $20 Meals for Imbruvica · 2022-07-25 · $24
Incyte	Monjuvi	$21	1 payment Meals for Monjuvi · 2022-06-17 · $21
Novartis Pharmaceuticals	Scemblix	$13	1 payment Meals for Scemblix · 2022-01-25 · $13

2021: $147

Sort by

Payments by company in 2021

Pharmacyclics LLC An AbbVie	Imbruvica	$119	1 payment Meals for Imbruvica · 2021-06-07 · $119
Amgen	Blincyto	$17	1 payment Meals for Blincyto · 2021-07-26 · $17
Genzyme	Sarclisa	$12	1 payment Meals for Sarclisa · 2021-08-30 · $12

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 76.5 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1831569391
Licence: CA NP95003142
Group: Stanford Health Care
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Nurse practitioner (363L00000X); Federal specialty code 363LA2100X (363LA2100X); Federal specialty code 363LA2200X (363LA2200X)
Mailing address: 300 Pasteur Dr, Stanford, CA, 94305
NPI first listed: 2015-09-28
NPI last updated: 2025-12-30
NPI record certified: 2025-12-30

This is when the NPI record was last certified, not a medical board exam.